Klaus Heidorn

1.3k citations
35 papers · 1.1k indexed · h-index 19
Topics
Telomeres, Telomerase, and Senescence (9 papers)Neuroblastoma Research and Treatments (5 papers)Acute Myeloid Leukemia Research (4 papers)

In The Last Decade

Klaus Heidorn

35 papers receiving 1.1k citations

Peers

Klaus Heidorn
Comparison fields: 5 of 89
  • Molecular Biology 492
  • Physiology 394
  • Oncology 232
  • Immunology 180
  • Surgery 124
Replace Rosalind Smith with:
Rosalind Smith United Kingdom
Brenda Kusler United States
Nikolaj Dietrich Denmark
Julie S. Martin United Kingdom
Meri T. Firpo United States
Valeriu B. Cismasiu Romania
Brian S. Garrison United States
N Hole United Kingdom
Yasushi Hamaguchi Japan
Cassandra D. Belair United States
Klaus Heidorn relative to Rosalind Smith United Kingdom Rosalind Smith's profile →
Citations per field
00.5×2.7×
Rosalind Smith · 1×
Citations per year

Countries citing papers authored by Klaus Heidorn

Since Specialization
Citations

This map shows the geographic impact of Klaus Heidorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Heidorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Heidorn more than expected).

Fields of papers citing papers by Klaus Heidorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Heidorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Heidorn. The network helps show where Klaus Heidorn may publish in the future.

Co-authorship network of co-authors of Klaus Heidorn

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Heidorn. A scholar is included among the top collaborators of Klaus Heidorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Heidorn. Klaus Heidorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 12
3 15
4 87
5 6
6 40
7 25
8 4
9 33
10 60
11
p53 analysis of laryngeal cancer in exon 4 to 9.
11
12 21
13 24
14 32
15 23
16 115
17
Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer.
62
18 13
19 23
20 1

About Klaus Heidorn

Klaus Heidorn is a scholar working on Aging, Hematology and Genetics, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (9 papers), Neuroblastoma Research and Treatments (5 papers) and Acute Myeloid Leukemia Research (4 papers). The work is most often cited by research in Aging (97 citations), Physiology (394 citations) and Immunology (180 citations). Klaus Heidorn has collaborated with scholars based in Germany, United States and Denmark. Frequent co-authors include Reza Parwaresch, Wolfram Klapper, Guido Krupp, Hans Kreipe, M. R. Parwaresch, H. J. Radzun, Pierre Rudolph, Kumud K. Singh, Sandra Tamm and Jürgen Barth. Their work appears in journals such as Nucleic Acids Research, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026